BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
BIOR
Delisted
BIOR was delisted on the 10th of December, 2024.
24 hedge funds and large institutions have $25.9M invested in Biora Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
20% less funds holding
Funds holding: 30 → 24 (-6)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Holders
24
Holding in Top 10
2
Calls
$2.34M
Puts
$161K
Top Buyers
| 1 | +$20M | |
| 2 | +$74.5K | |
| 3 | +$43.4K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.9K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$9.13K |
Top Sellers
| 1 | -$2.38M | |
| 2 | -$230K | |
| 3 | -$148K | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$84.7K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$65.7K |